PP_1170x120_10-25-21

generic medicines

Mylan, Teva roll out generic versions of Intuniv

Mylan, Teva roll out generic versions of Intuniv

NEW YORK — Mylan N.V. and Teva Pharmaceutical Industries Ltd. have released guanfacine extended-release tablets, a nonstimulant medication for attention deficit hyperactivity disorder (ADHD), in the United States. The pharmaceutical companies said Tuesday that their products, available in strengths of 1 mg, 2 mg, 3 mg and 4 mg, are generic equivalents of Intuniv from

Adheris Health